Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Vaccine Patch Shown Safe, Induces Immune Response

Nanopatch system

Initial results from a clinical trial show a patch device delivering a Covid-19 vaccine is well tolerated by recipients and triggers a measurable immune response. . . . → Read More: Vaccine Patch Shown Safe, Induces Immune Response

Clinical Trial Begins for Peanut Allergy Treatment

Bag of peanuts

A clinical trial is underway testing an experimental therapy for peanut allergy that its developer says trains the immune system without using peanut proteins. . . . → Read More: Clinical Trial Begins for Peanut Allergy Treatment

Self-Applied Patch Shown Feasible for Vaccine Delivery

Vaccine patch

A clinical trial shows a microneedle patch device for vaccine delivery applied by participants to their own arms works as well in the skin as when administered by clinicians. . . . → Read More: Self-Applied Patch Shown Feasible for Vaccine Delivery

Nasal Spray Reduces Flu Duration in Challenge Trial

3-D print of influenza virus

An influenza vaccine given as a nasal spray is shown in a clinical trial to reduce the amount of time participants have flu infections, when exposed to the virus. . . . → Read More: Nasal Spray Reduces Flu Duration in Challenge Trial

Clinical Trial Underway Testing Influenza Vaccine Patch

Nanopatch system

A clinical trial has begun testing a commercially-available flu vaccine administered with a painless patch device against conventional syringe injection delivery. . . . → Read More: Clinical Trial Underway Testing Influenza Vaccine Patch

Covid-19 Vaccine Patch Clinical Trial Begins

Vaccine patch

Developers of a patch with tiny needles instead of a syringe to deliver vaccines say a clinical trial testing a Covid-19 patch is now underway in Australia. . . . → Read More: Covid-19 Vaccine Patch Clinical Trial Begins

Early Trials Show Responses for Some Blood Cancers

Natural killer cell

First results from two clinical trials testing the safety of natural killer cell therapies show responses by patients with some forms of blood-related cancers. . . . → Read More: Early Trials Show Responses for Some Blood Cancers

Trial to Test AI-Designed Cancer Antibody Therapy

Cancer magnified

A clinical trial is set to begin evaluating a synthetic antibody treatment for solid tumor cancer designed with machine learning algorithms. . . . → Read More: Trial to Test AI-Designed Cancer Antibody Therapy

Brain-Computer Implant Found Safe After a Year

Stentrode illustration

A clinical trial shows an electronic prosthetic device sent into the brain does not cause serious adverse effects after a year in a small group of people with ALS. . . . → Read More: Brain-Computer Implant Found Safe After a Year

Start-Up to Discover Proteins for Difficult Drug Targets

Chemical atom model

A new biotechnology company designing proteins in the lab for difficult drug targets in a range of diseases is raising $100 million in venture funds. . . . → Read More: Start-Up to Discover Proteins for Difficult Drug Targets